GC–MS based Gestational Diabetes Mellitus longitudinal study: Identification of 2-and 3-hydroxybutyrate as potential prognostic biomarkers

Journal of Pharmaceutical and Biomedical Analysis

Volumn 144, Issue , 2017, Pages 90-98

  Dudzik, Danuta ^a   Zorawski, Marcin ^b   Skotnicki, Mariusz ^b   Zarzycki, Wieslaw ^b   García, Antonia ^a   Angulo, Santiago ^a   Lorenzo, M Paz ^a   Barbas, Coral ^a   Ramos, M Pilar ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

2 hydroxybutyrate; 3 hydroxybutyrate; Fingerprinting; Gas chromatography; Gestational diabetes mellitus; Maternal metabolism; Metabolomics; Type 2 diabetes mellitus

Indexed keywords

2 HYDROXYBUTYRATE; 3 HYDROXYBUTYRIC ACID; C PEPTIDE; C REACTIVE PROTEIN; GLUCONIC ACID; GLUCOSE; GLYCEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYACID; INSULIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; PROLINE; STEARIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC COMPLICATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; LONGITUDINAL STUDY; MASS FRAGMENTOGRAPHY; METABOLOMICS; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL; PREGNANCY; PROGNOSIS;

3-HYDROXYBUTYRIC ACID; BIOMARKERS; DIABETES, GESTATIONAL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LONGITUDINAL STUDIES; PILOT PROJECTS; PREGNANCY; PROGNOSIS;

EID: 85019680674     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2017.02.056     Document Type: Article

References (39)

1. American Diabetes Association, Diagnosis and classification of diabetes mellitus, Diabetes Care, 32 (Suppl. 1) (2009) S62–S67, doi:10.2337/dc09-S062.
2. Metzger, B.E., International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33 (2010), 676–682, 10.2337/dc09-1848.
3. Lowe, L.P., Coustan, D.R., Metzger, B.E., Hadden, D.R., Dyer, A.R., Hod, M., Lowe, J., Oats, J.J.N., Mccance, D.R., Persson, B., Lappin, T.R.J., Trimble, E.R., Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 35 (2012), 574–580, 10.2337/dc11-1687.
4. Catalano, P.M., Ehrenberg, H.M., The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG: Int. J. Obstet. Gynaecol. 113 (2006), 1126–1133, 10.1111/j.1471-0528.2006.00989.x.
5. Feig, D.S., Zinman, B., Wang, X., Hux, J.E., Risk of development of diabetes mellitus after diagnosis of gestational diabetes., CMAJ. Can. Med. Assoc. J.= Journal de l'Association Medicale Canadienne 179 (2008), 229–234, 10.1503/cmaj.080012.
6. Bellamy, L., Casas, J.-P., Hingorani, A.D., Williams, D., Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373 (2009), 1773–1779, 10.1016/S0140-6736(09)60731-5.
7. Lauenborg, J., Hansen, T., Jensen, D.M., Vestergaard, H., Mølsted-Pedersen, L., Hornnes, P., Locht, H., Pedersen, O., Damm, P., Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 27 (2004), 1194–1199 http://www.ncbi.nlm.nih.gov/pubmed/15111544 (Accessed 27 October 2016).
8. Kim, C., Newton, K.M., Knopp, R.H., Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care, 25, 2002.
9. Ferrannini, E., Natali, A., Camastra, S., Nannipieri, M., Mari, A., Adam, K.P., Milburn, M.V., Kastenmüller, G., Adamski, J., Tuomi, T., Lyssenko, V., Groop, L., Gall, W.E., Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62 (2013), 1730–1737, 10.2337/db12-0707.
10. Wang-Sattler, R., Yu, Z., Herder, C., Messias, A.C., Floegel, A., He, Y., Heim, K., Campillos, M., Holzapfel, C., Thorand, B., Grallert, H., Xu, T., Bader, E., Huth, C., Mittelstrass, K., Döring, A., Meisinger, C., Gieger, C., Prehn, C., Roemisch-Margl, W., Carstensen, M., Xie, L., Yamanaka-Okumura, H., Xing, G., Ceglarek, U., Thiery, J., Giani, G., Lickert, H., Lin, X., Li, Y., Boeing, H., Joost, H.-G., de Angelis, M.H., Rathmann, W., Suhre, K., Prokisch, H., Peters, A., Meitinger, T., Roden, M., Wichmann, H.-E., Pischon, T., Adamski, J., Illig, T., Novel biomarkers for pre-diabetes identified by metabolomics. Mol. Syst. Biol., 8, 2012, 615, 10.1038/msb.2012.43.
11. Allalou, A., Nalla, A., Prentice, K.J., Liu, Y., Zhang, M., Dai, F.F., Ning, X., Osborne, L.R., Cox, B.J., Gunderson, E.P., Wheeler, M.B., A predictive metabolic signature for the transition from gestational diabetes mellitus to type 2 diabetes. Diabetes 65 (2016), 2529–2539, 10.2337/db15-1720.
12. Yengo, L., Arredouani, A., Marre, M., Roussel, R., Vaxillaire, M., Falchi, M., Haoudi, A., Tichet, J., Balkau, B., Bonnefond, A., Froguel, P., Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling. Mol. Metab. 5 (2016), 918–925, 10.1016/j.molmet.2016.08.011.
13. Drogan, D., Dunn, W.B., Lin, W., Buijsse, B., Schulze, M.B., Langenberg, C., Brown, M., Floegel, A., Dietrich, S., Rolandsson, O., Wedge, D.C., Goodacre, R., Forouhi, N.G., Sharp, S.J., Spranger, J., Wareham, N.J., Boeing, H., Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin. Chem. 61 (2015), 487–497, 10.1373/clinchem.2014.228965.
14. Klein, M.S., Shearer, J., Metabolomics and type 2 diabetes: translating basic research into clinical application. J. Diabetes Res., 2016, 2016, 3898502, 10.1155/2016/3898502.
15. Varvel, S.A., Voros, S., Thiselton, D.L., Pottala, J.V., Dall, T., Warnick, G.R., McConnell, J.P., Ghaedi, L., Sasinowski, M., Graham, T., Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practice. J. Cardiovascu. Trans. Res. 7 (2014), 597–606, 10.1007/s12265-014-9577-1.
16. Newgard, C.B., Stedman, S.W., Interplay between lipids and branched-chain amino acids in development of insulin resistance, (n.d.). Cell Metab., 2016, 10.1016/j.cmet.2012.01.024.
17. Shah, S.H., Crosslin, D.R., Haynes, C.S., Nelson, S., Turer, C.B., Stevens, R.D., Muehlbauer, M.J., Wenner, B.R., Bain, J.R., Laferrère, B., Gorroochurn, P., Teixeira, J., Brantley, P.J., Stevens, V.J., Hollis, J.F., Appel, L.J., Lien, L.F., Batch, B., Newgard, C.B., Svetkey, L.P., Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 55 (2012), 321–330, 10.1007/s00125-011-2356-5.
18. Cobb, J., Eckhart, A., Motsinger-Reif, A., Carr, B., Groop, L., Ferrannini, E., α-Hydroxybutyric acid is a selective metabolite biomarker of impaired glucose tolerance. Diabetes Care 39 (2016), 988–995, 10.2337/dc15-2752.
19. Gall, W.E., Beebe, K., Lawton, K.A., Adam, K.P., Mitchell, M.W., Nakhle, P.J., Ryals, J.A., Milburn, M.V., Nannipieri, M., Camastra, S., Natali, A., Ferrannini, E., α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One, 5, 2010, 10.1371/journal.pone.0010883.
20. Lowe, W.L., Bain, J.R., Prediction is very hard, especially about the future: new biomarkers for type 2 diabetes?. Diabetes 62 (2013), 1384–1385, 10.2337/db13-0057.
21. Dudzik, D., Zorawski, M., Skotnicki, M., Zarzycki, W., Kozlowska, G., Bibik-Malinowska, K., Vallejo, M., García, A., Barbas, C., Ramos, M.P., Metabolic fingerprint of gestational diabetes mellitus. J. Proteom. 103 (2014), 57–71, 10.1016/j.jprot.2014.03.025.
22. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419 http://www.ncbi.nlm.nih.gov/pubmed/3899825 (Accessed 27 October 2016).
23. Katz, A., Nambi, S.S., Mather, K., Baron, A.D., Follmann, D.A., Sullivan, G., Quon, M.J., Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85 (2000), 2402–2410, 10.1210/jcem.85.7.6661.
24. Gika, H.G., Macpherson, E., Theodoridis, G.A., Wilson, I.D., Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 871 (2008), 299–305, 10.1016/j.jchromb.2008.05.048.
25. Garcia, A., Barbas, C., Gas chromatography-mass spectrometry (GC–MS)-based metabolomics. Methods Mol. Biol. (Clifton N.J.) 708 (2011), 191–204, 10.1007/978-1-61737-985-7_11.
26. Bro, R., Smilde, A.K., Principal component analysis. Anal. Methods, 6, 2014, 2812, 10.1039/c3ay41907j.
27. Smilde, A.K., Van Velzen, Æ.E.J.J., Van Duijnhoven, Æ.J.P.M., Van Dorsten, F.A., Assessment of PLSDA cross validation. Metabolomics, 2008, 81–89, 10.1007/s11306-007-0099-6.
28. G.R.H.S.M. (HUSERMET), Dunn, C.W.B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J.D., Halsall, A., Haselden, J.N., Nicholls, A.W., Wilson, I.D., Kell, D.B., Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6 (2011), 1060–1083, 10.1038/nprot.2011.335.
29. Salek, R.M., Maguire, M.L., Bentley, E., Rubtsov, D.V., Hough, T., Cheeseman, M., Nunez, D., Sweatman, B.C., Haselden, J.N., Cox, R.D., Connor, S.C., Griffin, J.L., A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol. Genom., 29, 2007.
30. Menni, C., Fauman, E., Erte, I., Perry, J.R.B., Kastenmüller, G., Shin, S.Y., Petersen, A.K., Hyde, C., Psatha, M., Ward, K.J., Yuan, W., Milburn, M., Palmer, C.N.A., Frayling, T.M., Trimmer, J., Bell, J.T., Gieger, C., Mohney, R.P., Brosnan, M.J., Suhre, K., Soranzo, N., Spector, T.D., Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62 (2013), 4270–4276, 10.2337/db13-0570.
31. Witt, H., Mueller, M., Padberg, I., Peter, E., Gonza, S., A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology. PLoS One, 9, 2014, 10.1371/journal.pone.0085082.
32. Xu, F., Tavintharan, S., Sum, C.F., Woon, K., Lim, S.C., Ong, C.N., Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. J. Clin. Endocrinol. Metab. 98 (2013), E1060–E1065, 10.1210/jc.2012-4132.
33. Sekhar, R.V., Mckay, S.V., Patel, S.G., Guthikonda, A.P., Reddy, V.T., Balasubramanyam, A., Jahoor, F., Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 34 (2011), 162–167, 10.2337/dc10-1006.
34. Montelongo, A., Lasunción, M.A., Pallardo, L.F., Herrera, E., Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes, 41, 1992.
35. Ma, W., Wu, J.H.Y., Wang, Q., Lemaitre, R.N., Mukamal, K.J., Djoussé, L., King, I.B., Song, X., Biggs, M.L., Delaney, J.A., Kizer, J.R., Siscovick, D.S., Mozaffarian, D., Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the cardiovascular health study. Am. J. Clin. Nutr. 101 (2015), 153–163, 10.3945/ajcn.114.092601.
36. Velagapudi, V.R., Hezaveh, R., Reigstad, C.S., Gopalacharyulu, P., Yetukuri, L., Islam, S., Felin, J., Perkins, R., Borén, J., Oresic, M., Bäckhed, F., The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 51 (2010), 1101–1112, 10.1194/jlr.M002774.
37. Lacroix, M., Kina, E., Hivert, M.-F., Maternal/fetal determinants of insulin resistance in women during pregnancy and in offspring over life. Curr. Diab. Rep. 13 (2013), 238–244, 10.1007/s11892-012-0360-x.
38. Lauenborg, J., Grarup, N., Damm, P., Borch-Johnsen, K., Jørgensen, T., Pedersen, O., Hansen, T., Common type 2 diabetes risk gene variants associate with gestational diabetes. J. Clin. Endocrinol. Metab. 94 (2009), 145–150, 10.1210/jc.2008-1336.
39. Kampmann, U., Madsen, L.R., Skajaa, G.O., Iversen, D.S., Moeller, N., Ovesen, P., Gestational diabetes: a clinical update. World J. Diabetes 6 (2015), 1065–1072, 10.4239/wjd.v6.i8.1065.